Filing Details
- Accession Number:
- 0001209191-12-057500
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-13 17:24:26
- Reporting Period:
- 2012-12-11
- Filing Date:
- 2012-12-13
- Accepted Time:
- 2012-12-13 17:24:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1292519 | Invivo Therapeutics Holdings Corp. | NVIV | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1503383 | Francis Reynolds | C/O Invivo Therapeutics Holdings Corp. One Kendall Square, Suite B14402 Cambridge MA 02139 | Ceo, Cfo | Yes | Yes | Yes | No |
Transaction Summary
| Sold: | 12,750 shares | Avg. Price: $1.64 | Total Value: $20,958.40 |
| Number of Shares After Transactions: | 14,352,160 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-12-11 | 3,420 | $1.67 | 14,361,490 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-11 | 30 | $1.70 | 14,361,460 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-11 | 800 | $1.73 | 14,360,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-12 | 1,550 | $1.61 | 14,359,110 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-12 | 700 | $1.62 | 14,358,410 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-12 | 350 | $1.65 | 14,358,060 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-12 | 1,650 | $1.70 | 14,356,410 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-13 | 4,250 | $1.60 | 14,352,160 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,603 | Indirect | By 401(k) Plan |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2012.
Billionaire Hedge Funds
